Bromantane and Enclomiphene Interaction

Avoid
Mechanism-based 64% confidence

Bromantane and Enclomiphene have a potentially harmful interaction with 64% confidence. Both Bromantane and Enclomiphene carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. These compounds primarily affect different organ systems.

Compound Profiles

Bromantane

Actoprotector | Dopamine Upregulation & Adaptive Energy

Bromantane's mechanism of action is fundamentally different from conventional stimulants and most nootropic compounds. Its primary action is the upregulation of tyrosine hydroxylase (TH) and aromatic L-amino acid decarboxylase (AADC) gene expression in the striatum and other dopaminergic brain regions.

Half-life: ~11 hours Typical dose: 50-100 mg/day cognitive
dopamine receptorgaba hepatotoxicteratogenic
View full profile

Enclomiphene

Selective Estrogen Receptor Modulator | Testosterone & Fertility Support

Enclomiphene competitively antagonizes estrogen receptors in the hypothalamus and anterior pituitary, blocking the negative feedback of estradiol on GnRH release. This disinhibition increases pulsatile GnRH secretion, which in turn stimulates the anterior pituitary to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH).

Half-life: ~10 hours Typical dose: 12.5-25mg oral daily pct, sexual health
estrogen receptorserotonin receptor hepatotoxicpct agentteratogenic
View full profile

Combined Organ Load

Brain
low
Gonads
low
Pituitary
low

Shared Safety Flags

2x 2 hepatotoxic compounds (Bromantane, Enclomiphene). Liver damage risk significantly increased. Include liver support (TUDCA/NAC) and monitor ALT/AST.
2x 2 compounds share the teratogenic safety flag (Bromantane, Enclomiphene). Monitor accordingly.

Frequently Asked Questions

Can I take Bromantane with Enclomiphene?

Combining Bromantane with Enclomiphene is not recommended. Both Bromantane and Enclomiphene carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently.

Is Bromantane and Enclomiphene safe together?

This combination carries significant risk. Both Bromantane and Enclomiphene carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. Consult a healthcare professional before combining.

What are the interactions between Bromantane and Enclomiphene?

Both Bromantane and Enclomiphene carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. This assessment has 64% confidence and is inferred from pharmacological mechanism analysis.

How should I time Bromantane and Enclomiphene?

Bromantane has a half-life of ~11 hours and Enclomiphene has a half-life of ~10 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Bromantane vs Enclomiphene

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.